School of Medicine
Showing 1-10 of 223 Results
-
Neda Kaboodvand
Basic Life Res Scientist, Neurosurgery
Current Role at StanfordNeda Kaboodvand, PhD, is an Applied Research Scientist at Stanford University School of Medicine. Her research lies at the intersection of artificial intelligence, behavioral science, and clinical research, with a focus on using multimodal data to understand human behavior and improve clinical decision-making. She designs and leads experimental and observational studies and develops machine learning, statistical, and computational models to evaluate interventions, predict outcomes, and support personalized, adaptive approaches to care. A central part of her work involves modeling complex longitudinal and time-series data, including neural, electrophysiological, physiological, behavioral, imaging, and device-generated signals. By integrating these high-dimensional data sources, she develops models of patient and user state, identifies temporal patterns associated with outcomes and intervention response, and translates complex data into actionable insights for clinical and digital health systems.
-
Alexander D. Kaiser
Instructor, Cardiothoracic Surgery
BioAlexander Kaiser, PhD, is an applied mathematician and computational scientist who researches modeling and simulation of heart valves, focused on congenital heart valve disease and its surgical treatment. His recent research explores simulation-guided design of aortic valve repair of complex congenital heart defects. He has developed novel, nearly first-principles modeling methods for heart valves called elasticity-based design. These methods produce robust and realistic flows in fluid-structure interaction simulations. Dr. Kaiser is an Instructor in Cardiothoracic Surgery at Stanford University working with Michael Ma and Alison Marsden. He completed his PhD in Mathematics with Charles Peskin at the Courant Institute of Mathematical Sciences at New York University, where he was awarded the Kurt O. Friedrichs Prize for Outstanding Dissertation in Mathematics.
-
Sharada Kalanidhi
Director of Data Science, Biochemistry - Genome Center
Current Role at StanfordCurrent Research: Mathematical Medicine
The essential challenge is not merely to solve a problem, but to discover the mathematical framework in which the problem can be understood — a perspective associated with the mathematician Alexander Grothendieck.
We spent decades using sophisticated mathematics to understand financial markets. What happens when we bring that same mathematical direction—and deeper ideas from pure mathematics—to understanding human biology?
This question captures the intellectual motivation behind Sharada's current work: developing the foundations of Mathematical Medicine, a proposed new discipline that draws on pure mathematics to address fundamental challenges in individualized diagnosis, personalized therapeutics, cancer treatments, and healthy longevity.
The work begins with a central challenge in contemporary medicine. Advances in genomics, proteomics, metabolomics, and computational biology have generated unprecedented volumes of biomedical data. Yet translating these measurements into meaningful insights for individual patients remains difficult, particularly for those with rare, complex, or previously unexplained conditions.
Conventional statistical and machine learning approaches have transformed biomedical research, but their reliance on population-level patterns can limit their usefulness when an individual patient's biology differs substantially from that of available reference cohorts. Clinically meaningful differences may be treated as statistical noise or outliers rather than investigated as potential clues to underlying disease mechanisms.
After more than a decade of research and collaboration with biochemists at SGTC, Sharada became increasingly interested in whether the mathematical foundations used to interpret biomedical data were sufficient for the complexity of individualized medicine.
Her central premise is that progress in personalized medicine may require not simply more data or larger computational models, but new mathematical ways of understanding biological systems.
Rather than applying existing statistical approaches to biomedical problems, Mathematical Medicine explores whether ideas from pure mathematics can fundamentally change how biological questions are formulated, understood, and solved.
The research is guided by the possibility that deeper mathematical understanding can reveal - and preserve- meaningful biological relationships even when data are limited, heterogeneous, or difficult to interpret using conventional approaches.
This approach echoes a perspective expressed by the mathematician Mikhail Gromov: “This area does not yet exist. It will have to be invented.”
It also reflects the empirical philosophy associated with the mathematician and quantitative investor Jim Simons: “We don't start with models. We start with data. We don't have any preconceived notions.” The aim is to allow biological observations to guide mathematical inquiry, rather than forcing them into existing computational frameworks.
Sharada's research has contributed to investigations of complex and previously unexplained clinical conditions, including cases in which mathematical and multi-omic analyses helped identify potential diagnoses and therapeutic pathways. These investigations also motivate broader questions about how individual biological differences can inform our understanding of disease.
The long-term vision is to establish Mathematical Medicine as a rigorous discipline connecting pure mathematics, molecular biology, and clinical medicine—advancing mathematics toward a foundation for understanding individual biology, preserving biological mechanisms and informing clinical decisions.
Further information about Mathematical Medicine, its research vision, and opportunities for early philanthropic partnerships is available at:
https://mathmed-2026.web.app/